Marinus Pharmaceuticals Inc News - MRNS

	Real-time Prices	Level 2
Australian Stock Exchange

Professional-Grade Tools, for Individual Investors.

Premium

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

ZTALMY® (ganaxolone) Q3 2024 net product revenue of $8.5 million representing growth of 56% versus Q3 2023 Narrowing full year 2024 ZTALMY net...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives

Trial did not meet the primary endpoint of percent change in 28-day TSC-associated seizure frequency (p=0.09); results showed numerically higher...

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure...

Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens

New U.S. patent issued for ZTALMY® (ganaxolone) oral titration regimens cover the treatment of a range of epilepsy disorders, expiring September...

glenn1919 3 months ago

MNRS................................https://stockcharts.com/h-sc/ui?s=MNRS&p=W&b=5&g=0&id=p86431144783

👍️0

Money hunt 7 months ago

1.27 Wall gong to get busted down Watch out shorties,

👍️0

Money hunt 7 months ago

MRNS Has got bulls with balls dude

👍️0

Money hunt 7 months ago

Watch out shorties We the Next PALI So you can all burn in hell where you belong

👍️0

ErnieBilco 7 months ago

MRSN under $2

👍️0

Awl416 7 months ago

Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results

👍️0

Monksdream 8 months ago

MRNS under $10

👍️0

oldstocks 9 months ago

Drug Companies making Epilepsy medication
MRNS $10.08
CERE $43.16
STOK $4.98
UCBJF $102.00
SNY $45.63
PFE $27.00
OTSUK $18.36
RespireRx Pharmaceuticals Ticker: RSPI
Is working on Revolutionary New Hope:
KRM-II-81 Drug-Resistant Epilepsy Patients

Don't take my word for it, look at the links that talk about it.

Link found on National Library of Medicine
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders

https://pubmed.ncbi.nlm.nih.gov/35041859/

https://www.neurexplain.com/2024/01/17/revolutionary-krm-ii-81-a-new-hope-for-drug-resistant-epilepsy-patients/

National Institutes of Health
A clinical case of a 19-year-old male patient with pharmacoresistant seizures occurring following parieto-occipital tumor-resection at age 6 ...
KRM–II–81 suppresses epileptifom activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784158/

👍️0

matt51 1 year ago

Has Marinus enrolled the eighty-second patient for the phase 3 RSE trial?

👍️0

Cosa 2 years ago

Did you add more here? This recovered well from the bottom. I was putting all into ARDX and AUPH, didn't add any here.

Ha, our time is coming for MRNS Cosa, also check out MIRM

👍️0

Cosa 3 years ago

Good thing that's all you had lol! This is definitely not volatile enough to trade. And a good investment?...Time will tell.

👍️0

missile_systems 3 years ago

Yeah Buddy…. Hoping for good news.
Just stumbled upon this on Friday afternoon.
Only had enough powder to grab a hundred shares.
Please don’t laugh too hard….lol.

Anyway, it’s weird that there haven’t been any posts on this board since before last Christmas!

Peace
mis

👍️0

Cosa 3 years ago

let's see what happens Monday...

👍️0

Cosa 3 years ago

Everything I have is Red, not a single green. lol!

👍️0

flsh56 3 years ago

... don't look now, it's been six months since this happened, but mrns just decently broke through their 50dma

Cosa, good to see you on this board, MRNS - like AUPH - is primed to pop.

👍️0

whytestocks 4 years ago

JUST IN: $MRNS 3 Biotech Stocks That Surged Last Week

Dozens of healthcare stocks grew by double-digit percentages last week, and shares of these three drugmakers rose further than nearly all of their peers. Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers la...

Read the whole news MRNS - 3 Biotech Stocks That Surged Last Week

👍️0

ClayTrader 4 years ago

* * $MRNS Video Chart 09-15-2020 * *

Link to Video - click here to watch the technical chart video

whytestocks 4 years ago

NEWS: $MRNS Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4

4 Penny Stocks To Buy Right Now According To Analysts Whether you buy penny stocks because of analysts or simply use ratings in your overall strategy, it helps to get a full lay of the land. What I mean by this is that most retail traders will look at a few facets of certain companies. They...

Find out more MRNS - Top Penny Stocks To Buy, Sell Or Hold? Analysts Weigh In On These 4

👍️0

whytestocks 4 years ago

Breaking News: $MRNS Nasdaq Rises Despite Nikola Hit; Marinus Soars

Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were no...

Got this from MRNS - Nasdaq Rises Despite Nikola Hit; Marinus Soars

👍️0

UFO 4 years ago

Just announced phase #3 results rocked. Stock is on the way to $10+.

UFO

👍️0

MKthe great 4 years ago

whytestocks 4 years ago

News: $MRNS Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

Clinical trials remain on track, with Refractory Status Epilepticus (SE) trial expected to begin enrollment shortly CDKL5 deficiency disorder (CDD) pivotal topline results on track for Q3; Conference call to be scheduled to discuss CDD data release and business update Organiz...

Find out more MRNS - Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

ClayTrader 4 years ago

* * $MRNS Video Chart 05-29-2020 * *

Link to Video - click here to watch the technical chart video

agribusiness72 5 years ago

minor pump from yahoo finance. will see how low it drops before buying in.

👍️0

UFO 5 years ago

Looks like a move is on.

UFO

👍️0

ClayTrader 5 years ago

* * $MRNS Video Chart 03-16-2020 * *

Link to Video - click here to watch the technical chart video

👍️0

ClayTrader 5 years ago

* * $MRNS Video Chart 02-20-2020 * *

Link to Video - click here to watch the technical chart video

👍️0

ClayTrader 5 years ago

* * $MRNS Video Chart 02-18-2020 * *

Link to Video - click here to watch the technical chart video

👍️0

nuclear profitz 5 years ago

breaking out.

👍️0

Cosa 5 years ago

Good points. I'm sure they will find something it works on. The science behind it is still unknown. The good thing about ganaxolone is it has very little side effects. So if one of the phases does well it is a gold mine! I traded on the momentum and will get back in a little cheaper and a lot less shares so there is no stress lol.

I like Epidiolex seems to be gaining momentum since it's FDA approval last year. It targets the same symptoms of ganaxolone with very little side effects also.

Good luck to you!

👍️0

UFO 5 years ago

All I've seen them have an issue with is one trial. Now they have a treasure chest full of money and some aggressive money manager backing. IMHO, this would be the WORST time to bail out on the company. Did you read the corporate outlook that was released today? They have about 4 trials in progress and the ability to fund them all. You think ganaxolone is going to fail on all of them? I like the odds here. At the least I think we'll see a rally into the Phase 3 results that we'll see later this year. Go Marinus!

UFO

👍️0

Cosa 5 years ago

The more I research this stock the more I do not like. Ganaxolone doesnt look like it is doing well in clinical trials.

👍️0

ClayTrader 5 years ago

* * $MRNS Video Chart 12-24-2019 * *

Link to Video - click here to watch the technical chart video

👍️0

Cosa 5 years ago

Could see that big move up sometime next month

https://www.nasdaq.com/articles/implied-volatility-surging-for-marinus-pharmaceuticals-mrns-stock-options-2019-12-23

👍️0

UFO 5 years ago

Agreed. I've never seen a stock rally like this as a "major" financing is going on! Somebody knows something...just saying...

UFO

👍️0

Cosa 5 years ago

Possible 10 bagger with a short squeeze.

ClayTrader 5 years ago

* * $MRNS Video Chart 12-20-2019 * *

Link to Video - click here to watch the technical chart video

👍️0

UFO 5 years ago

If they get GREAT results from their phase 3, this is a $40 - $50 stock!

UFO

👍️0

Cosa 5 years ago

If they pass a phase 3 this is going to $10 - $16

👍️0

Cosa 5 years ago

I'm late to the party. Just got in, more room to grow

👍️0

UFO 5 years ago

Gap higher! Where are all you Marinus holders? This baby is on the move!

UFO

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Marinus Pharmaceuticals Inc (MRNS)

Professional-Grade Tools, for Individual Investors.

MRNS News

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting

Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens

MRNS Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Marinus Pharmaceuticals Inc (MRNS) News

Marinus Pharmaceuticals Inc (MRNS)

Professional-Grade Tools, for Individual Investors.

MRNS News

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives

Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting

Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens

MRNS Discussion

Your Recent History

Company

Business

Popular

Get The App

BLACK FRIDAY

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%